Researchers Identify Protein That Protects Cells Against RNA Viruses
Researchers say the discovery is essential to developing future therapies to limit viral infection and improve the health of patients with chronic lung disease.
Researchers say the discovery is essential to developing future therapies to limit viral infection and improve the health of patients with chronic lung disease.
A peer-reviewed study in The Lancet Respiratory Medicine found that an inhaled form of interferon may be used to treat hospitalized Covid-19 patients.
The National Institutes of Health has initiated a randomized, controlled clinical trial evaluating the safety and efficacy of the antiviral remdesivir (Gilead Sciences) plus the immunomodulator interferon beta-1a (Merck) in patients with COVID-19.
Researchers are seeking a new strategy to quantify the total number of wildlife viruses that could potentially cause infectious disease outbreaks.
Read More